Long Island City, N.Y., May 11, 2022 — Pandemic Response Lab, a wholly-owned subsidiary of Opentrons Labworks, Inc., today announced it has received the College of American Pathologists accreditation for its New York City laboratory, notably with zero deficiencies, following a rigorous CAP inspection. The announcement comes weeks after PRL… Read More
Eva Boratto joins as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer joins as chief legal and compliance officer Long Island City, N.Y., March 15, 2022 — Opentrons Labworks, Inc., today announced the appointments of Eva Boratto as chief financial officer and member of the board… Read More
Solutions enable labs to run more efficiently at a fraction of the cost. Brooklyn, N.Y., March 10, 2022 — Opentrons Robotics today announced the largest expansion of its automation portfolio to date, launching four new OT-2 workstation products supporting popular applications, including NGS, PCR and protein purification. These launches build on… Read More
PRL have encountered a small percentage of the BA.2 Omicron variant. Our PCR test continues to remain effective against SARS-CoV-2 and known variants. Pandemic Response Lab’s reliable, low cost, rapid PCR and whole genome sequencing capabilities are crucial for ongoing vigilance against new SARS-CoV-2 variants. To date, our… Read More
Quick turnaround time and genomic surveillance capability support new variant detection for COVID-19 New York, NY – December 3rd, 2021: Today, Pandemic Response Lab (PRL), part of Opentrons Labworks Inc., reported the discovery of the first four Omicron cases in New York City. The announcement was made by Governor Kathy Hochul… Read More
Opentrons App Software Update 4.6.0 releases the Opentrons Protocol Timer, which instantly estimates the duration of any protocol you create. Hello there 👋! We just released our next software update: 4.6.0. This update includes a new feature: the Opentrons Protocol Timer. It will generate an even more… Read More
Opentrons will use this funding to scale its automated lab platform for life sciences and healthcare. NEW YORK, NY – SEPTEMBER 23TH, 2021: Today Opentrons Labworks Inc. has announced SoftBank Vision Fund 2* has led the company’s $200 million Series C investment with participation by Khosla Ventures. Opentrons will use… Read More
